Recent Updates
Recently added Catalysts
BNR Positive Sentiment

Burning Rock Announces ADS Ratio Change

Key Takeaway: Burning Rock Biotech Limited announced a modification in its American depositary shares (ADS) ratio, transitioning from one ADS for one Class A ordinary share to one ADS for ten shares. This change, set to take effect around May 15, 2024, is likened to a one-for-ten reverse split. While the company anticipates a proportional increase in ADS prices, it does not guarantee that the post-change price will be at least ten times the previous price. The company continues to focus on next generation sequencing technology in precision oncology, with ongoing efforts in therapy selection testing and cancer detection.
Price reaction · baseline $8.5005 (2024-04-25 close) · hit after-hours · clean, no other BNR news in the window
day 0 close
0%

Market Sentiment Analysis

POSITIVE FACTORS

  • The company is implementing a change that may increase the ADS price proportionally.
  • The ADS Ratio Change aims to enhance trading of the ADSs on stock exchanges.
  • Burning Rock's focus on precision oncology is promising for future growth.

CONCERNS & RISKS

  • There is no guarantee that the ADS price will increase tenfold after the change.
  • Holders of certificated ADSs must actively surrender their shares, which could be inconvenient.

Full Press Release Details

Burning Rock Announces ADS Ratio Change
GUANGZHOU, China, April 26, 2024 Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the Company or Burning Rock ), a company
focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that it will change the ratio of its American depositary shares (the ADSs ) to Class A ordinary shares from
one (1) ADS representing one (1) Class A ordinary share to one (1) ADS representing ten (10) Class A ordinary shares (the ADS Ratio Change ). The ADS Ratio Change is expected to become effective on or about
May 15, 2024 (the Effective Date ).
For Burning Rock s ADS holders, the ADS Ratio Change will have the same effect as a one-for-ten reverse ADS split. There will be no change to the Company s Class A ordinary shares. On the Effective Date, registered holders of the Company s ADSs
held in certificated form will be required on a mandatory basis to surrender their certificated ADSs to Citibank, N.A., the depositary bank (the Depositary ), for cancellation and will receive one (1) new ADS in exchange for every
ten (10) existing ADSs surrendered. Holders of uncertificated ADSs in the Direct Registration System and The Depository Trust Company will have their ADSs automatically exchanged and need not take any action. The exchange of every ten
(10) then-held (existing) ADSs for one (1) new ADS will occur automatically at the Effective Date, with the then-held ADSs being cancelled and new ADSs being issued by the Depositary. Burning Rock s ADSs will continue to be traded on
the NASDAQ Global Market and London Stock Exchange under the symbol BNR .
No fractional new ADSs will be issued in connection with the change
in the ADS Ratio Change. Instead, fractional entitlements to new ADSs will be aggregated and sold by the Depositary and the net cash proceeds from the sale of the fractional ADS entitlements will be distributed to the applicable ADS holders by the
Depositary, in each case in accordance with the Depositary s then current procedures and practices and after any deductions as provided in the deposit agreement between the Company and the Depositary for the ADSs.
As a result of the ADS Ratio Change, the ADS price is expected to increase proportionally, although the Company can give no assurance that the ADS price after
the ADS Ratio Change will be equal to or greater than ten times the ADS price before the change.
Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR), whose mission is to guard life via science, focuses on the application of next generation sequencing
(NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy selection testing for late-stage cancer patients, and ii) cancer early detection, which has moved beyond proof-of-concept R&D into the clinical validation stage.
information about Burning Rock, please visit: ir.brbiotech.com.
Safe Harbor Statement
This press release contains forward-looking statements. These statements constitute forward-looking statements within the meaning of
Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as will,
expects, anticipates, future, intends, plans, believes, estimates, target, confident and similar statements. Burning Rock may also make
written or oral forward-looking statements in its periodic reports to the SEC, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties.
Statements that are not historical facts, including statements about Burning Rock s beliefs and expectations, are forward-looking statements. Such statements are based upon management s current expectations and current market and operating
conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond Burning Rock s control. Forward-looking statements involve risks,
uncertainties and other factors that could cause actual results to differ materially from those contained in any such statements. All information provided in this press release is as of the date of this press release, and Burning Rock does not
undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

Frequently Asked Questions

What is the new ADS ratio for Burning Rock?

The new ADS ratio is one ADS representing ten Class A ordinary shares.

When will the ADS ratio change take effect?

The ADS ratio change will take effect on or about May 15, 2024.

Do ADS holders need to take action for the exchange?

Holders of uncertificated ADSs will be automatically exchanged without action.

What happens to fractional ADSs after the change?

Fractional ADS entitlements will be sold, and proceeds distributed to holders.

Will the ADS price increase after the ratio change?

The ADS price is expected to rise, but a proportional increase is not guaranteed.

Last updated: Apr 26, 2024